Janney Montgomery Scott
TGTX icon

Janney Montgomery Scott’s TG Therapeutics TGTX Stock Holding History

Janney Montgomery Scott’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,995
Closed -$90K – 2051
2018
Q3 		$90K Hold
15,995
– – ﹤0.01% 2005
2018
Q2 		$210K Sell
15,995
-315
-2% -$4.33K ﹤0.01% 1832
2018
Q1 		$232K Buy
+16,310
New +$208K ﹤0.01% 1736

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janney Montgomery Scott's TGTX Position: Q4 2018 in Review

Janney Montgomery Scott sold out of TG Therapeutics (TGTX) in Q4 2018, closing a stake of 15,995 shares — an estimated $90K sold.

Janney Montgomery Scott first reported a position in TGTX in Q1 2018 and held it in 3 quarters. The position peaked at $232K in Q1 2018. 115 funds tracked by Wall St. Rank hold TGTX as of Q4 2018.

  • Janney Montgomery Scott reported no remaining TG Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 15,995 TG Therapeutics shares in Q4 2018, an estimated $90K.
  • Janney Montgomery Scott first reported a position in TG Therapeutics in Q1 2018 and held it in 3 quarters.
  • Janney Montgomery Scott's TG Therapeutics position peaked at $232K in Q1 2018.
  • 115 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2018.

Based on Janney Montgomery Scott's 13F filing for Q4 2018, filed 1 Feb 2019.